Search FHI 360

Start a New Search

Search within these results

Contraceptive technology innovationReproductive and sexual healthResearch

Search

9 Results Found

• Event

  FHI 360 at the International Conference on Family Planning 2022

  FHI 360 is pleased to join the global community of family planning and sexual and reproductive health experts at the International Conference on Family Planning (ICFP) 2022. For over 50 years, FHI 360 has been providing cutting-edge leadership in...
• Published research

  Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial
• Published research

  Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: A multicenter phase 3 trial
• Published research

  Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa
• Published research

  Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women’s preferences in India and Nigeria
• Published research

  Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
• News

  Award will continue work to advance contraceptive technology innovation

  The Bill & Melinda Gates Foundation granted a four-year award to expand and strengthen ongoing development and evaluation of new contraceptives, under the Contraceptive Technology Innovation (CTI) Initiative.
• Feature

  Removing cost and access barriers to contraceptive implants (audio)

  Markus Steiner and Kate Rademacher of FHI 360 discuss the long-term effort to increase global access to contraceptive implants at an affordable price.
• Past Project

  Contraceptive Technology Innovation (CTI) Initiative

  The goal of the Contraceptive Technology Innovation Initiative is to develop new contraceptives that ensures access to quality, affordable and acceptable products for those most in need.